KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $510,102 | +14.3% | 36,698 | +89.0% | 0.04% | -4.9% |
| Q2 2023 | $446,420 | +87.3% | 19,418 | +141.5% | 0.04% | -28.1% |
| Q1 2023 | $238,284 | +3871.4% | 8,042 | +2912.0% | 0.06% | +5600.0% |
| Q3 2022 | $6,000 | -40.0% | 267 | -46.4% | 0.00% | -50.0% |
| Q2 2022 | $10,000 | +233.3% | 498 | +582.2% | 0.00% | +100.0% |
| Q1 2022 | $3,000 | -25.0% | 73 | +5.8% | 0.00% | 0.0% |
| Q4 2021 | $4,000 | -92.0% | 69 | -91.9% | 0.00% | -94.4% |
| Q3 2021 | $50,000 | +4900.0% | 848 | +3292.0% | 0.02% | – |
| Q2 2021 | $1,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |